For pain providers, staying clinically current is essential. Staying legally compliant is equally so, in an enforcement environment that has grown significantly more sophisticated, more data-driven, and more willing to pursue individual clinicians rather than just institutions. Understanding what that enforcement landscape looks like today and how to stay ahead of it is no longer optional.
Enforcement Has Changed. Has Your Compliance Program Kept Pace?
Federal enforcement activity targeting pain management providers has escalated in scale and focus over the past several years. What began as a campaign against high-volume pill mills has evolved into a sophisticated, data-driven effort that now trains its sights on individual licensed clinicians. Regulators are using prescribing data and billing analytics to proactively identify targets, often long before a provider is aware they are under scrutiny. Understanding how this enforcement ecosystem works, who is in it, and what signals tend to put a provider on a regulator’s radar is the first step toward managing that risk.
The Risk Is Not Just Criminal
Many providers think of compliance risk as something that only becomes serious if it rises to the level of criminal charges. In reality, the path from a routine payor audit to a criminal referral can move faster than most anticipate. Documentation deficiencies, improper billing, Stark Law and Anti-Kickback issues, and financial relationships with pharmacies, labs, or DME suppliers can each generate civil liability on their own. Left unaddressed, civil findings can escalate. Recognizing the difference between civil and criminal exposure is critical. The patterns that draw enforcement attention often start small, and early intervention is almost always more cost-effective than a reactive response.
Telehealth Is Under the Microscope
The pandemic-era telehealth waivers that expanded access to controlled substance prescribing without in-person evaluations were a lifeline for patients with limited mobility or geographic access to care. They were also, in some cases, a vector for abuse. As those waivers expire and regulators turn their attention to telehealth models that prioritized volume over clinical rigor, providers who treated telehealth as a compliance-light environment are now facing heightened scrutiny. Understanding the current telehealth risk curve, the documentation standards that apply, and how to reassess protocols to stay on the right side of the Ryan Haight Act and DEA guidance has never been more important for providers operating in this space.
What to Expect at PAINWeek 2026
To learn more about navigating these risks, join the presentation “Future-Proofing Compliance for Pain Providers” at PAINWeek 2026, taking place September 8-11 in Las Vegas. This presentation goes beyond a review of the current rules to address the practical, strategic questions that keep pain management clinicians up at night: How do I know if my documentation is adequate? What do I do when I receive an audit letter? Where are my greatest areas of exposure? Whether you are a solo practitioner, part of a large group practice, or working in an institutional setting, attendees will leave with legal perspective and actionable guidance they can put to work immediately.
About Frier Levitt
Frier Levitt is experienced in advising pain management providers on federal enforcement matters, compliance program development, and the civil and criminal risks that arise from prescribing and billing practices. As regulators continue to target individual clinicians and scrutiny of telehealth models intensifies, Frier Levitt helps providers assess their exposure, strengthen their compliance programs, and respond effectively when enforcement activity begins. Contact Frier Levitt to review your compliance program and ensure your practice is protected.
